BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21632098)

  • 1. Clinical, colposcopic and pathological characteristics of cervical and vaginal high-grade lesions negative for HPV by Hybrid Capture 2.
    del Pino M; Rodriguez-Carunchio L; Alonso I; Torné A; Rodriguez A; Fusté P; Castillo P; Nonell R; Abu-Lhiga N; Ordi J
    Gynecol Oncol; 2011 Sep; 122(3):515-20. PubMed ID: 21632098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
    Holladay EB; Logan S; Arnold J; Knesel B; Smith GD
    Cancer; 2006 Dec; 108(6):451-61. PubMed ID: 17078096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
    Belinson JL; Hu S; Niyazi M; Pretorius RG; Wang H; Wen C; Smith JS; Li J; Taddeo FJ; Burchette RJ; Qiao YL
    Int J Cancer; 2010 Sep; 127(5):1151-7. PubMed ID: 20039323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia.
    Guo M; Hu L; Baliga M; He Z; Hughson MD
    Am J Clin Pathol; 2004 Dec; 122(6):894-901. PubMed ID: 15539381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of semi-quantitative HPV viral load estimation by Hybrid capture 2 in colposcopy practice.
    Basu P; Muwonge R; Mittal S; Banerjee D; Ghosh I; Panda C; Mandal R; Sankaranarayanan R
    J Med Screen; 2016 Jun; 23(2):104-10. PubMed ID: 26566949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring.
    De Vivar AD; Dawlett M; Wang JP; Jack A; Gong Y; Staerkel G; Guo M
    Arch Pathol Lab Med; 2015 Feb; 139(2):219-24. PubMed ID: 25611104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic Outcomes in HPV-Positive and Cervical Cytology- Negative Women - Screening Results in Northern Thailand.
    Vijakururote L; Suprasert P; Srisomboon J; Siriaunkgul S; Settakorn J; Rewsuwan S
    Asian Pac J Cancer Prev; 2015; 16(16):7271-5. PubMed ID: 26514523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
    Solares C; Velasco J; Álvarez-Ruiz E; González-Fernández L; Encinas AI; Astudillo A; Schneider J
    Anticancer Res; 2015 Nov; 35(11):6291-5. PubMed ID: 26504065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cervical cancer in high-risk populations: DNA pap test or Hybrid Capture II test alone?
    Miranda Pereira SM; Castelo A; Makabe S; Utagawa ML; Di Loreto C; Sakamoto Maeda MY; Marques JA; Santoro CL; Filho AL; Das Dores GB
    Int J Gynecol Pathol; 2006 Jan; 25(1):38-41. PubMed ID: 16306782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile.
    Hampl M; Wentzensen N; Vinokurova S; von Knebel-Doeberitz M; Poremba C; Bender HG; Kueppers V
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):235-45. PubMed ID: 17294241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of Hybrid Capture II detection of high-risk human papillomavirus in women with abnormal pap-smears of the uterine cervix].
    Tena D; Garrido N; Menéndez JM; Delgado JJ; Romanyk J; González Mdel R; Zapico A; Beltrán M
    Enferm Infecc Microbiol Clin; 2005 Oct; 23(8):474-8. PubMed ID: 16185561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
    Monsonego J; Pintos J; Semaille C; Beumont M; Dachez R; Zerat L; Bianchi A; Franco E
    Int J Gynecol Cancer; 2006; 16(2):591-8. PubMed ID: 16681731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions.
    Gage JC; Schiffman M; Solomon D; Wheeler CM; Castle PE
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1668-74. PubMed ID: 20615884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the performance of HPV tests in women with abnormal cytology: results of a study within the NHS cervical screening programme.
    Moss SM; Bailey A; Cubie H; Denton K; Sargent A; Muir P; Vipond IB; Winder R; Kitchener H
    Cytopathology; 2015 Dec; 26(6):373-80. PubMed ID: 25274541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.